Empyema in a patient treated with infliximab: it is not what it seems

Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for M...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2005-11, Vol.64 (11), p.1657-1658
Hauptverfasser: Bossink, A, Thijsen, S, van Houte, A J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for MBL codon variants. 3 It is tempting to speculate that the immunomodulating effect of infliximab contributed to the two episodes of thoracic empyema.
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.2004.034959